Late-Stage Functionalization and Characterization of Drugs by High-Throughput Desorption Electrospray Ionization Mass Spectrometry.
Kai-Hung HuangJyotirmoy GhoshShiqing XuRobert Graham CooksPublished in: ChemPlusChem (2022)
Late-stage functionalization (LSF) of drug molecules is an approach to generate modified molecules that retain functional groups present in the active drugs. Here, we report a study that seeks to characterize the potential value of high-throughput desorption electrospray ionization mass spectrometry (HT DESI-MS) for small-scale rapid LSF. In conventional route screening, HT-based DESI-MS provides contactless, rapid analysis, reliable and reproducible data, minimal sample requirement, and exceptional tolerance to high salt concentrations. Ezetimibe (E), an established hypertension drug, is targeted for modification by LSF. C-H alkenylation and azo-click reactions are utilized to explore this approach to synthesis and analytical characterization. The effect of choice of reactant, stoichiometry, catalyst, and solvent are studied for both reactions using high throughput DESI-MS experiments. Optimum conditions for the formation of LSF products are established with identification by tandem mass spectrometry (MS/MS).
Keyphrases
- mass spectrometry
- high throughput
- liquid chromatography
- tandem mass spectrometry
- high performance liquid chromatography
- ultra high performance liquid chromatography
- gas chromatography
- capillary electrophoresis
- high resolution mass spectrometry
- ms ms
- simultaneous determination
- single cell
- high resolution
- ionic liquid
- solid phase extraction
- blood pressure
- drug induced
- loop mediated isothermal amplification
- multiple sclerosis
- cancer therapy
- big data
- room temperature
- human health
- risk assessment
- adverse drug
- decision making
- electronic health record
- machine learning
- sensitive detection
- reduced graphene oxide
- carbon dioxide